高清国产亚洲精品自在久久,亚洲精品国产911在线观看

Like2291 2019-08-05 13:38 IP：重慶

◆◆

1、Effect of probenecid or diet on tebipenem pivoxil tablets pharmacokinetics in healthy male volunteers； 2、Effect of diet on the pharmacokinetics of tebipenem pivoxil fine granules in healthy male volunteers； 3、Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infection 1、Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects. Jin C, Jeon JY, Im YJ, Jeong JA, Kim Y, Chae SW, Bentz J, Kumke T, Kim MG. 7.The control of myopia with atropine. [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

4

Like2291 2019-08-02 11:39 IP：重慶

◆◆

需要20篇文獻(xiàn)

1.Myopia Control with Bifocal Contact Lenses:?A Randomized Clinical Trial 2.The Role of Atropine Eye Drops in Myopia Control 4. Myopia Control: A Review 7. Efficacy of 1%?atropine?eye drops in retarding progressive axial myopia in Indian eyes 8.Atropine?0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia 9.Current approaches to myopia control 10.Atropine?for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines 13. Atropine?0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia. 18. The treatment of myopia with?atropine?and bifocals. A long-term prospective study 19. Inhibitory effects of apomorphine and?atropine?and their combination on myopia in chicks 20. The penetration and distribution of topical?atropine?in animal ocular tissues. 21. Treatment outcomes of?myopic?anisometropia with 1%?atropine: a pilot study 23. Does?atropine?use increase intraocular pressure in?myopic?children? 24. Atropine?use for the prevention of myopia progression 25. Allergic reactions to?atropine?eye drops for retardation of progressive myopia in children. 29. Maximum?atropine?dose without clinical signs or symptoms. 31. Atropine?and bifocals can slow the progression of myopia in children. 33. Prevention of myopia onset with 0.025%?atropine?in premyopic children 35. The long-term results of using low-concentration?atropine?eye drops for controlling myopia progression in schoolchildren. 37. Prevention of myopia progression with 0.05%?atropine?solution. [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥100.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥100.00

已托管

載入中...

23

Steve_Olson 2019-08-01 16:24 IP：重慶

◆◆

企業(yè)規(guī)范名核對(duì)與規(guī)范

根據(jù)已知企業(yè)名稱（寫法不規(guī)范）去CFDA http://app1.sfda.gov.cn/datasearchcnda/face3/base.jsp?tableId=25&tableName=TABLE25&title=%B9%FA%B2%FA%D2%A9%C6%B7&bcId=152904713761213296322795806604 或藥智數(shù)據(jù)https://db.yaozh.com/pijian 查找對(duì)應(yīng)的規(guī)范企業(yè)名稱無法確認(rèn)的需備注好原因規(guī)范數(shù)據(jù)按照0.05元/條（10000條500元）備注數(shù)據(jù)按照0.01元/條（10000條100元）準(zhǔn)確率要求98%。 [更多]

特色服務(wù)>>數(shù)據(jù)查詢

懸賞：￥2880.00

㖃特色服務(wù)>>數(shù)據(jù)查詢

懸賞

￥2880.00

已托管

載入中...

4

Like2291 2019-07-25 11:23 IP：重慶

◆◆

需要4篇文獻(xiàn)，1篇德國藥典

1、P. A. Prajapati and M. M. Patel, “Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect,”?International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 2, pp. 70–78, 2010.?View at Google Scholar 2、D. S. Satya, K. P. Suria, and P. P. Muthu, “Advanced approaches and evaluation of ocular drug delivery system,”?American Journal of PharmTech Research, vol. 1, no. 4, pp. 72–92, 2011.?View at Google Scholar 3、B. K. Nanjwade, D. B. Sonaje, and F. V. Manvi, “In vitro—in vivo?release of ciprofloxacin from ophthalmic formulations,”?International Journal of Pharmacy and Biotechnology, vol. 1, no. 1, pp. 23–28, 2011.?View at Google Scholar 4、Physicochemical properties and stability of nicorandil By Nagai, Hiroshi; Koizumi, Ikue; Haneda, Masatoshi; Imai, Toshikatsu; Kikuchi, Mineo; Shiba, Motoharu From Iyakuhin Kenkyu (1983), 14(6), 968-79. Language: Japanese, Database: CAPLUS 5、Sobean oil partially hydrogenated 最新德國藥典 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

1

小驛 2019-07-11 14:25 IP：重慶

◆◆

高價(jià)征集醫(yī)藥項(xiàng)目信息，一條信息500元

各位朋友，藥智谷主要為針對(duì)園區(qū)服務(wù)，現(xiàn)有全國多個(gè)園區(qū)委托藥智谷招商，引入醫(yī)藥、大健康企業(yè)或項(xiàng)目，現(xiàn)高價(jià)懸賞醫(yī)藥項(xiàng)目信息，區(qū)域不限，只需提供信息，一經(jīng)核實(shí)立賞500元，懸賞以下類型項(xiàng)目信息： 1、醫(yī)藥健康類企業(yè)準(zhǔn)備對(duì)外建分廠、新公司，想尋找園區(qū)或找地方落地的； 2、醫(yī)藥健康類創(chuàng)業(yè)想入駐園區(qū)或找地方落地的； 3、醫(yī)藥健康類企業(yè)有想搬遷新址，還在尋找地方的；信息格式如下：企業(yè)、項(xiàng)目名稱：XXXX 項(xiàng)目投資負(fù)責(zé)人+聯(lián)系電話：XXX（187XXXX5133）需求簡(jiǎn)述：信息提供人+電話：XXX（187XXXX5133）注意：為防止征集項(xiàng)目重復(fù)，請(qǐng)?jiān)诘谝淮瓮稑?biāo)填寫信息時(shí)，只需要填寫企業(yè)、項(xiàng)目名稱，藥智谷確認(rèn)不重復(fù)后，再行提交上述全部信息，在藥智谷打電話核實(shí)屬實(shí)后，給予賞金兌現(xiàn)！ [更多]

項(xiàng)目合作>>其他合作

懸賞：￥5000.00

㖃項(xiàng)目合作>>其他合作

懸賞

￥5000.00

已托管

載入中...

4

likezwh 2019-07-08 15:03 IP：珠海

◆◆

本公司擬并購中成藥生產(chǎn)銷售企業(yè)

標(biāo)題：本公司擬并購中成藥生產(chǎn)銷售企業(yè) 詳細(xì)要求： 1、產(chǎn)品要求：必須有治療心腦血管、“三高”、代謝性疾病中成藥產(chǎn)品和批文。 2、銷售要求：心腦血管、“三高”、代謝性疾病中成藥產(chǎn)品銷售已進(jìn)入醫(yī)院，并具備一定市場(chǎng)份額。 3、企業(yè)成長(zhǎng)時(shí)間較長(zhǎng)，有較好的歷史文人背景。 4、廠址以廣東省為主，其它省也可考慮。 5、如有保健食品產(chǎn)品和批文及生產(chǎn)線更佳。 6、廠區(qū)最好有預(yù)留生產(chǎn)車間或預(yù)留建筑用地。 7、提供擬轉(zhuǎn)讓企業(yè)負(fù)責(zé)人聯(lián)系方式，如確符合要求，可多人中標(biāo)。 [更多]

項(xiàng)目合作>>融資并購

懸賞：￥100.00

㖃項(xiàng)目合作>>融資并購

懸賞

￥100.00

已托管

載入中...

4

admin1111 2019-07-05 15:57 IP：南京

◆◆

需要推薦有維生素系列一致性評(píng)價(jià)需求的公司

我們公司承接維生素系列一致性評(píng)價(jià)工作（維生素C注射液，維生素B2、B6注射液），希望能推薦有需要的客戶，聯(lián)系人以及聯(lián)系方式. 我公司承諾一致性評(píng)價(jià)不通過全額退款。 [更多]

項(xiàng)目合作>>技術(shù)合作

懸賞：￥500.00

㖃項(xiàng)目合作>>技術(shù)合作

懸賞

￥500.00

已托管

載入中...

1

Like2291 2019-07-03 15:59 IP：重慶

◆◆

需要5篇文獻(xiàn)

1.Arzneimittel Forschung/Drug research 1986 36(2)，p291-303. 2.The use of antithrombotic drugs in artery disease 3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR). 4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624. 5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥50.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥50.00

已托管

載入中...

1

Like2291 2019-06-26 09:11 IP：重慶

◆◆

需要9篇文獻(xiàn)

1、Drugs Fut 1989, 14(9): 875 ISSN 0377-8282 Copyright Clarivate Analytics CCC: 0377-8282 DOI: 10.1358/dof.1989.014.09.103408 2、Dionne, G. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0526253; JP 1995500317; US 5538975; WO 9303027 . 3、Hoshi, A.; Casta?er, J.; Capecitabine. Drugs Fut 1996, 21, 4, 358 4、Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1997, vol. 36, # 9, p. 816 - 818 5、DETERMINATION OF CLENBUTEROL HYDROCHLORIDE BY SEQUENTIAL INJECTION ANALYSIS COUPLED WITH CHEMILUMINESCENCE DETECTION 6、[Bioanalytic examination and pharmacokinetics of captopril. Bioequivalence studies of different captopril-containing Tensiomin preparations]. 7、Agrati A. M., De Bartolo G., Palmieri G., Minerva Med., 83, 533-536(1992) 8、Dawes J., Hodson B. A., Pepper D. S., Thromb. Haemost, 62, 945-949(1989) 9、with mercury(II) diacetate,trifluoroacetic acid . Acta Chimica Hungarica 1986 vol.122 3-4 p261-272 [更多]

特色服務(wù)>>信息服務(wù)

懸賞：￥90.00

㖃特色服務(wù)>>信息服務(wù)

懸賞

￥90.00

已托管

載入中...

4

Sophiav_v 2019-06-25 16:44 IP：上海

◆◆

我司需要進(jìn)行5個(gè)產(chǎn)品的一致性評(píng)價(jià)BE試驗(yàn)

我們公司有5個(gè)產(chǎn)品目前在進(jìn)行一致性評(píng)價(jià)，其中兩個(gè)產(chǎn)品需要進(jìn)行正式BE試驗(yàn)，已完成在印度的預(yù)BE試驗(yàn)，有意長(zhǎng)期合作的CRO公司請(qǐng)聯(lián)系我。 [更多]

生產(chǎn)研發(fā)>>臨床試驗(yàn)

懸賞：￥50.00

㖃生產(chǎn)研發(fā)>>臨床試驗(yàn)

懸賞

￥50.00

已托管

載入中...

6

當(dāng)前位置：  首頁 > 需求大廳

㔍我要出現(xiàn)在這里 推薦任務(wù)

㔍我要出現(xiàn)在這里
推薦任務(wù)